Melagatran - Moligand™, ≥95% , Inhibitor of coagulation factor II; thrombin, CAS No.159776-70-2, Inhibitor of coagulation factor II; thrombin

CAS: 159776-70-2 Cat. No.: M352749 Summenformel: C22H31N5O4 Molekulargewicht: 429.51 EG-Nummer: 849-493-1
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥95%
Synonyms
((R)-2-((S)-2-((4-carbamimidoylbenzyl)carbamoyl)azetidin-1-yl)-1-cyclohexyl-2-oxoethyl)glycine|N-((R)-(((2S)-2-((p-Amidinobenzyl)carbamoyl)-1-azetidinyl)carbonyl)cyclohexylmethyl)glycine|2-(((R)-2-((S)-2-((4-Carbamimidoylbenzyl)carbamoyl)azetidin-1-yl)-1-cyclohexyl-2-oxoethyl)amino)acetic acid|Glycine, N-[(1R)-2-[(2S)-2-[[[[4-(aminoiminomethyl)phenyl]methyl]amino]carbonyl]-1-azetidinyl]-1-cyclohexyl-2-oxoethyl]-|MELAGATRAN [MI]|Glycine, N-((1R)-2-((2S)-2-((((4-(aminoiminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-1-cyclohexyl-2-oxoethyl)-|N-[(1R)-2-{(2S)-2-[(4-carbamimidoylbenzyl)carbamoyl]azetidin-1-yl}-1-cyclohexyl-2-oxoethyl]glycine|Melagatran|N-((R)-(((2S)-2-((-p-Amidobenzyl)carbamoyl)-1-azetidinyl)carbonyl)cyclohexylmethyl)glycine|Melagatran (INN)|MELAGATRAN (ASTRA-ZENECA)|2-[[(1R)-2-[(2S)-2-[(4-carbamimidoylphenyl)methylcarbamoyl]azetidin-1-yl]-1-cyclohexyl-2-oxoethyl]amino]acetic acid|Glycine, N-(2-(2-((((4-(aminoiminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-1-cyclohexyl-2-oxoethyl)-, (S-(R*,S*))-|[((1R)-2-{(2S)-2-[({4-[AMINO(IMINO)METHYL]BENZYL}AMINO)CARBONYL]AZETIDINYL}-1-CYCLOHEXYL-2-OXOETHYL)AMINO]ACETIC ACID|Melagatran [INN]|Melagatran AstraZeneca|MELAGATRAN [MART.]|MELAGATRAN [WHO-DD]|N-[(1R)-2-[(2S)-2-[[[[4-(Aminoiminomethyl)phenyl]methyl]amino]carbonyl]-1-azetidinyl]-1-cyclohexyl-2-oxoethyl]glycine
Storage
Lagerung bei -20°C
Shipped In
Eistruhe + Eispads
★
Größe
Deutschland (EU)
USA*
Preis
Menge
1mg
M352749-1mg
Auf Bestellung · 8–12 Wochen
187,34€
5mg
M352749-5mg
Auf Bestellung · 8–12 Wochen
622,08€
10mg
M352749-10mg
Auf Bestellung · 8–12 Wochen
980,46€
25mg
M352749-25mg
Auf Bestellung · 8–12 Wochen
1.921,96€
Enter a quantity for the sizes you want to add.

Übersicht

Melagatran ist ein Wirkstoff, der die Expression von Gewebefaktor in heterotypischen Komplexen aus menschlichen Blutplättchen und Monozyten verhindert. Studien deuten darauf hin, dass Melagatran in PRP-Gerinnungsmodellen eine fibrinolytische Aktivität hervorruft, die mit derjenigen vergleichbar ist, die in plättchenarmen Modellen beobachtet wird, die aus Gewebefaktor-induzierten Gerinnseln bestehen. Darüber hinaus wurde in diesen Studien festgestellt, dass die Fibrinolysefähigkeit von Melagatran durch das Vorhandensein von Blutplättchen nicht beeinträchtigt wird. Melagatran wirkt sich dosisabhängig auf die Thrombozytenaggregation aus, wobei niedrige Konzentrationen die größere Wirksamkeit haben. Außerdem wurde vermutet, dass Melagatran die γ-Thrombin/PAR-4-Rezeptoren gegenüber den α-Thrombin/PAR-1-Rezeptoren differenziell hemmen kann.

Spezifikationen

Synonyme
((R)-2-((S)-2-((4-carbamimidoylbenzyl)carbamoyl)azetidin-1-yl)-1-cyclohexyl-2-oxoethyl)glycine | N-((R)-(((2S)-2-((p-Amidinobenzyl)carbamoyl)-1-azetidinyl)carbonyl)cyclohexylmethyl)glycine | 2-(((R)-2-((S)-2-((4-Carbamimidoylbenzyl)carbamoyl)azetidin-1-yl)-1-cyclohexyl-2-oxoethyl)amino)acetic acid | Glycine, N-[(1R)-2-[(2S)-2-[[[[4-(amino Show more
Spezifikationen & Reinheit
Moligand™, ≥95%
Storage
Lagerung bei -20°C
Verschickt in
Eistruhe + Eispads
Note
Moligand™
Aktionsart
INHIBITOR
Mechanismus der Wirkung
Inhibitor of coagulation factor II; thrombin
Reinheit
≥95%
Namen und Kennungen
Kanonisches Lächeln
C1CCC(CC1)C(C(=O)N2CCC2C(=O)NCC3=CC=C(C=C3)C(=N)N)NCC(=O)O
IUPAC Name
2-[[(1R)-2-[(2S)-2-[(4-carbamimidoylphenyl)methylcarbamoyl]azetidin-1-yl]-1-cyclohexyl-2-oxoethyl]amino]acetic acid
InChIKey
DKWNMCUOEDMMIN-PKOBYXMFSA-N
INCHI
1S/C22H31N5O4/c23-20(24)16-8-6-14(7-9-16)12-26-21(30)17-10-11-27(17)22(31)19(25-13-18(28)29)15-4-2-1-3-5-15/h6-9,15,17,19,25H,1-5,10-13H2,(H3,23,24)(H,26,30)(H,28,29)/t17-,19+/m0/s1
Isomere SMILES
C1CCC(CC1)[C@H](C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)C(=N)N)NCC(=O)O
Molekulargewicht
429.51
Reaxy-Rn
25276972
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=25276972&ln=

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic acids and derivatives
KlasseCarboxylic acids and derivatives
SubclassAmino acids, peptides, and analogues
Intermediate Tree Nodes Peptides
Direct ParentDipeptides
Alternative Parents Alpha amino acid amides  Alpha amino acids  Benzene and substituted derivatives  Tertiary carboxylic acid amides  Secondary carboxylic acid amides  Amino acids  Azetidines  Monocarboxylic acids and derivatives  Azacyclic compounds  Dialkylamines  Carboxamidines  Carboxylic acids  Carboximidamides  Carbonyl compounds  Organic oxides  Hydrocarbon derivatives  Organopnictogen compounds  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents Alpha-dipeptide - Alpha-amino acid amide - Alpha-amino acid - Alpha-amino acid or derivatives - Monocyclic benzene moiety - Benzenoid - Tertiary carboxylic acid amide - Amino acid or derivatives - Amino acid - Azetidine - Carboxamide group - Secondary carboxylic acid amide - Amidine - Azacycle - Carboxylic acid amidine - Organoheterocyclic compound - Carboxylic acid - Secondary aliphatic amine - Monocarboxylic acid or derivatives - Secondary amine - Carboximidamide - Carbonyl group - Organopnictogen compound - Organic nitrogen compound - Amine - Organic oxide - Organonitrogen compound - Organooxygen compound - Hydrocarbon derivative - Organic oxygen compound - Aromatic heteromonocyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
External Descriptors carboxamidine - dicarboxylic acid monoamide - secondary amino compound - non-proteinogenic alpha-amino acid - azetidines
3D-Struktur
Interaktives chemisches Strukturmodell





Zugehörige Ziele (menschlich)
PLAT Tclin Tissue-type plasminogen activator (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PLG Tclin Plasminogen (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
F2 Tclin Prothrombin (14 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLG Tclin Plasminogen (2339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRSS1 Tclin Trypsin I (2306 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F11 Tchem Coagulation factor XI (1733 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLAT Tclin Tissue-type plasminogen activator (1057 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLAU Tchem Urokinase-type plasminogen activator (2016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F7 Tchem Coagulation factor VII (948 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PROC Tchem Vitamin K-dependent protein C (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC22A1 Tchem Solute carrier family 22 member 1 (646 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LRRC59 Tbio Leucine-rich repeat-containing protein 59 (3 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VPS35 Tbio Vacuolar protein sorting-associated protein 35 (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Zugehörige Ziele (nicht menschlich)
Trypsin (394 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

4 results found

Lot NumberCertificate TypeDatumArtikel
D2630415D2630415Certificate of AnalysisApr 27, 2026 M352749
D2630418D2630418Certificate of AnalysisApr 27, 2026 M352749
D2630419D2630419Certificate of AnalysisApr 27, 2026 M352749
D2630420D2630420Certificate of AnalysisApr 27, 2026 M352749
Chemische und physikalische Eigenschaften
LöslichkeitSolubility:DMSO
EmpfindlichkeitLight sensitive;Heat sensitive
Schmelzpunkt (°C)172-177° C
Molekulargewicht429.500 g/mol
XLogP3-1.000
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count6
Rotatable Bond Count9
Exact Mass429.238 Da
Monoisotopic Mass429.238 Da
Topological Polar Surface Area149.000 Ų
Heavy Atom Count31
Formal Charge0
Complexity671.000
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Lösungsrechner
Bewertungen

Kundenbewertungen

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.